Hepatoblastoma - 26 Studies Found
Active, not recruiting |
: Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy :
|
Active, not recruiting |
: Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors :
|
Completed |
: A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB :
: Drug: LDE225 LDE225/sonidegib capsules were supplied to the Investigators at dose strengths of 50 mg, 10 |
Not yet recruiting |
: Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors :
|
Not yet recruiting |
: G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor :
|
Recruiting |
: Understanding Communication in Healthcare to Achieve Trust (U-CHAT) :
|
Recruiting |
: Auto Transplant for High Risk or Relapsed Solid or CNS Tumors :
|
Withdrawn |
: Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors :
|
Recruiting |
: Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors :
: |